Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nezam Afdhal

Showing results (21-30 of 71) with videos related to

Pageof 8
Sort By:
The American Journal of Managed Care|July 19, 2019
Changing demographics among populations prescribed HCV treatment, 2013-2017Naoky Tsai, Bruce Bacon, Michael Curry, et al.
Gastroenterology|November 13, 2010
Changes in insulin sensitivity and body weight during and after peginterferon and ribavirin therapy for hepatitis CHari S Conjeevaram, Abdus S Wahed, Nezam Afdhal, et al.
Hepatology (Baltimore, Md.)|January 29, 2015
Treatment with ledipasvir and sofosbuvir improves patient-reported outcomes: Results from the ION-1, -2, and -3 clinical trialsZobair M Younossi, Maria Stepanova, Patrick Marcellin, et al.
Journal of Gastroenterology and Hepatology|August 28, 2010
Comparison of transient elastography, serum markers and clinical signs for the diagnosis of compensated cirrhosisRaza Malik, Michelle Lai, Amama Sadiq, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 22, 2004
Hepatic CD1d expression in hepatitis C virus infection and recognition by resident proinflammatory CD1d-reactive T cellsEmanuele Durante-Mangoni, RuoJie Wang, Angela Shaulov, et al.
Journal of Hepatology|March 22, 2015
Improvement of health-related quality of life and work productivity in chronic hepatitis C patients with early and advanced fibrosis treated with ledipasvir and sofosbuvirZobair M Younossi, Maria Stepanova, Nezam Afdhal, et al.
Gastroenterology|January 4, 2003
Liver fibrosis: insights into migration of hepatic stellate cells in response to extracellular matrix and growth factorsChangqing Yang, Michael Zeisberg, Barbara Mosterman, et al.
Plos One|May 29, 2015
Performance of an Optimized Paper-Based Test for Rapid Visual Measurement of Alanine Aminotransferase (ALT) in Fingerstick and Venipuncture SamplesSidhartha Jain, Radha Rajasingham, Farzad Noubary, et al.
Hepatology (Baltimore, Md.)|October 11, 2011
Natural killer inhibitory receptor expression associated with treatment failure and interleukin-28B genotype in patients with chronic hepatitis CLucy Golden-Mason, Kiran M Bambha, Linling Cheng, et al.
Antimicrobial Agents and Chemotherapy|February 15, 2018
Sofosbuvir and Ribavirin Liver Pharmacokinetics in Patients Infected with Hepatitis C VirusDarius Babusis, Michael P Curry, Brian Kirby, et al.
Pageof 8

Showing results (21-30 of 71) with videos related to

Sort By:
Pageof 8
The American Journal of Managed Care|July 19, 2019
Changing demographics among populations prescribed HCV treatment, 2013-2017Naoky Tsai, Bruce Bacon, Michael Curry, et al.
Gastroenterology|November 13, 2010
Changes in insulin sensitivity and body weight during and after peginterferon and ribavirin therapy for hepatitis CHari S Conjeevaram, Abdus S Wahed, Nezam Afdhal, et al.
Hepatology (Baltimore, Md.)|January 29, 2015
Treatment with ledipasvir and sofosbuvir improves patient-reported outcomes: Results from the ION-1, -2, and -3 clinical trialsZobair M Younossi, Maria Stepanova, Patrick Marcellin, et al.
Journal of Gastroenterology and Hepatology|August 28, 2010
Comparison of transient elastography, serum markers and clinical signs for the diagnosis of compensated cirrhosisRaza Malik, Michelle Lai, Amama Sadiq, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 22, 2004
Hepatic CD1d expression in hepatitis C virus infection and recognition by resident proinflammatory CD1d-reactive T cellsEmanuele Durante-Mangoni, RuoJie Wang, Angela Shaulov, et al.
Journal of Hepatology|March 22, 2015
Improvement of health-related quality of life and work productivity in chronic hepatitis C patients with early and advanced fibrosis treated with ledipasvir and sofosbuvirZobair M Younossi, Maria Stepanova, Nezam Afdhal, et al.
Gastroenterology|January 4, 2003
Liver fibrosis: insights into migration of hepatic stellate cells in response to extracellular matrix and growth factorsChangqing Yang, Michael Zeisberg, Barbara Mosterman, et al.
Plos One|May 29, 2015
Performance of an Optimized Paper-Based Test for Rapid Visual Measurement of Alanine Aminotransferase (ALT) in Fingerstick and Venipuncture SamplesSidhartha Jain, Radha Rajasingham, Farzad Noubary, et al.
Hepatology (Baltimore, Md.)|October 11, 2011
Natural killer inhibitory receptor expression associated with treatment failure and interleukin-28B genotype in patients with chronic hepatitis CLucy Golden-Mason, Kiran M Bambha, Linling Cheng, et al.
Antimicrobial Agents and Chemotherapy|February 15, 2018
Sofosbuvir and Ribavirin Liver Pharmacokinetics in Patients Infected with Hepatitis C VirusDarius Babusis, Michael P Curry, Brian Kirby, et al.
Pageof 8